18.01.2019 Drägerwerk AG & Co. KGaA  DE0005550602

DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Dräger releases preliminary results for 2018 and forecast for 2019


 

DGAP-Ad-hoc: Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/Forecast
Drägerwerk AG & Co. KGaA: Dräger releases preliminary results for 2018 and forecast for 2019

18-Jan-2019 / 16:38 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Dräger hereby announces preliminary, unaudited figures for fiscal year 2018.
 
Order intake rose by approximately 2.2 percent over the course of the year (approximately 5.4 percent net of currency effects). Net sales increased by roughly 1.0 percent (approximately 4.0 percent net of currency effects) to some EUR 2.60 billion (2017: EUR 2.57 billion). The EBIT margin is expected to have stood between 2.3 percent and 2.8 percent (2017: 6.1 percent) in 2018.
 
Net sales growth and the EBIT margin therefore stood within the range most recently forecast by Dräger (currency-adjusted net sales growth of between 2.0 and 5.0 percent and an EBIT margin of between 2.0 and 3.5 percent).
 
Besides negative currency effects, the scheduled higher expenditures for the strengthening of R&D and Sales also played a decisive role in the decline in earnings development. In addition, unplanned expenses in Logistics and Quality Assurance strained earnings. The gross margin was roughly 1.5 percentage points lower year on year (2017: 44.8 percent).
 
While all three regions reported a positive order intake trend, net sales development varied from region to region. Net sales rose by just over one percent in the Europe region (approximately 3 percent net of currency effects) and by roughly 3 percent in Asia, Africa, and Australia (approximately 6 percent net of currency effects), whereas the Americas region recorded a decline in net sales of around 2 percent (approximately 4.5 percent increase net of currency effects).
 
Against the backdrop of increasing macroeconomic risks, Dräger anticipates a decline in growth momentum. The company expects to see currency-adjusted net sales growth of between 1.0 and 4.0 percent in fiscal year 2019 (2018: currency-adjusted growth of around 4.0 percent). The current exchange rates would result in negligible currency effects on the reported net sales growth (2018: approximately -3 percentage points) for the year 2019 as a whole. The necessary investments in the strengthening of R&D as well as Sales, which started in the past fiscal year, will be continued in 2019. Profitability may therefore fall below the current level in 2019. Dräger forecasts an EBIT margin of between 1.0 and 3.0 percent. 
The aforementioned estimates of net sales and margin performance are based on the assumption of unchanged foreign exchange rates and do not include restructuring charges.

 
Dräger is set to present its full and audited financial statements for fiscal year 2018 on Thursday, March 7, 2019.
 
Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck, Deutschland
www.draeger.com
 
 
 
Investor Relations:
Thomas Fischler
Tel. +49 451 882-2685
[email protected]
 
Corporate Communications:
Melanie Kamann
Tel. +49 451 882-3998
[email protected]
 
 
Disclaimer
This ad hoc report contains statements on the future development of Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to date. They were compiled to the best of the company's knowledge. Dräger does not provide any warranty nor assume any responsibility for the future developments and results described above. These are dependent on a number of factors. They entail various risks and contingencies outside of the company's influence and are based on assumptions which could prove to be incorrect. Dräger does not assume any responsibility for updating the forward-looking statements contained in this report. This does not infringe any legal stipulations on the adjustment of forecasts. Please go to Investor Relations / Definitions of financial indicators at www.draeger.com for information on alternative performance measures used.
 
 

18-Jan-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23542 Lübeck
Germany
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
E-mail: [email protected]
Internet: www.draeger.com
ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000 555 067 7, DE 000 555 071 9
WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067 Genussschein K, 555071 Genussschein D
Indices: SDAX, TecDAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich; Regulated Unofficial Market in Stuttgart, Tradegate Exchange

 
End of Announcement DGAP News Service

767549  18-Jan-2019 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=767549&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 2.572,26 2.595,01 2.780,82 3.406,78 3.328,42 3.045,23 3.375,50
EBITDA1,2 240,00 147,91 193,71 521,07 421,00 55,80 315,00
EBITDA-Marge3 9,33 5,70 6,97 15,30 12,65 1,83
EBIT1,4 155,74 62,65 66,58 396,60 271,68 -88,61 166,43
EBIT-Marge5 6,05 2,41 2,39 11,64 8,16 -2,91 4,93
Jahresüberschuss1 98,50 34,90 33,79 249,89 154,27 -63,64 111,99
Netto-Marge6 3,83 1,34 1,22 7,34 4,64 -2,09 3,32
Cashflow1,7 143,34 4,09 164,42 459,98 384,89 -144,23 189,68
Ergebnis je Aktie8 4,12 1,42 1,38 10,19 7,13 -3,41 5,86
Dividende8 0,40 0,13 0,13 0,13 0,13 0,13 0,13
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: -

INVESTOR-INFORMATIONEN
©boersengefluester.de
Drägerwerk ST
WKN Kurs in € Einschätzung Börsenwert in Mio. €
555060 45,300 Kaufen 897,99
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
8,39 17,24 0,49 12,34
KBV KCV KUV EV/EBITDA
0,62 4,48 0,27 3,60
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,13 1,74 3,84 08.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
25.04.2024 25.07.2024 29.10.2024 07.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
4,73% 8,81% 1,34% 20,64%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Drägerwerk AG & Co. KGaA  ISIN: DE0005550602 können Sie bei EQS abrufen


Medtech , 555060 , DRW8 , XETR:DRW8